Pressors, short for vasopressors, are powerful medications used in hospitals to raise dangerously low blood pressure. They work by tightening blood vessels, strengthening the heart’s pumping force, or both. If someone you know is “on pressors” in an ICU, it means their blood pressure has dropped low enough that their organs are at risk, and these drugs are keeping blood flowing where it needs to go.
How Pressors Work
Your body maintains blood pressure through two main levers: how hard the heart pumps and how tight the blood vessels are. Pressors act on one or both of these. They do this by activating specific receptors on the walls of blood vessels and on heart muscle cells. When a pressor activates receptors called alpha receptors on blood vessels, those vessels constrict and blood pressure rises. When it activates beta receptors on the heart, the heart beats harder and faster, pushing more blood out with each beat.
Some pressors primarily squeeze blood vessels. Others mainly boost the heart. Many do a combination of both, which is why doctors choose specific pressors depending on the type of problem causing the low blood pressure.
There’s a related category of drugs called inotropes, which focus specifically on making the heart contract more forcefully without necessarily tightening blood vessels. In practice, many drugs overlap between these categories. Dopamine, for example, acts as both a vasopressor and an inotrope depending on the dose. At moderate doses it increases heart rate and pumping strength. At higher doses it shifts toward tightening blood vessels.
Why Someone Might Need Pressors
Pressors are reserved for serious, often life-threatening situations where blood pressure has fallen so low that organs like the kidneys, brain, and heart aren’t getting enough blood. The medical term for this is shock, and it comes in several forms.
Septic shock is the most common reason. This happens when a severe infection triggers a massive inflammatory response that causes blood vessels to relax and leak. In a large trial published in the New England Journal of Medicine, septic shock accounted for about 62% of patients needing pressors, followed by cardiogenic shock (when the heart itself is too weak to pump effectively) at roughly 17%, and hypovolemic shock (from blood or fluid loss) at about 16%.
Other situations that call for pressors include neurogenic shock from spinal cord injuries, where the nervous system loses its ability to keep blood vessels appropriately constricted, and severe allergic reactions (anaphylaxis) that cause a sudden drop in vascular tone.
The Most Common Pressors
Norepinephrine is the go-to first choice for most types of shock. The Surviving Sepsis Campaign, the leading international guideline for managing sepsis, recommends it as the first-line agent. It works by activating both alpha and beta receptors, meaning it tightens blood vessels and gives the heart a moderate boost at the same time. The initial target is a mean arterial pressure (MAP) of 65 mm Hg, which is the minimum pressure needed to keep blood flowing to vital organs.
When norepinephrine alone isn’t enough, doctors typically add a second pressor. The two most common additions are vasopressin and epinephrine. Vasopressin works through a completely different mechanism than the other pressors. Instead of acting on the same adrenaline-type receptors, it activates its own dedicated receptors on blood vessels, which makes it a useful complement. Epinephrine is a potent stimulator of both blood vessels and the heart, making it particularly useful when the heart needs extra support alongside blood pressure maintenance.
Phenylephrine is a pure vessel-constrictor. It tightens blood vessels without speeding up the heart, which makes it useful in specific situations where an increased heart rate would be harmful. Dopamine was historically popular as a first-line option, but a major randomized trial comparing it to norepinephrine found it was associated with more side effects, particularly abnormal heart rhythms. It’s now used less frequently as a first choice.
How Pressors Are Given
Pressors are delivered through an IV, traditionally into a large central vein in the neck or near the collarbone using a central venous catheter. This has been the standard approach because these drugs are extremely potent and need precise, continuous delivery.
However, placing a central line takes time, specialized skill, and carries its own risks. Current guidelines now support starting pressors through a regular peripheral IV in the arm or hand when a central line isn’t immediately available. This is especially important in emergency departments where every minute of low blood pressure causes more organ damage. Studies in ICU settings have found that peripheral vasopressor infusions running for a median of 24 hours did not cause significant complications, suggesting they can be safely used for longer periods than previously thought.
Regardless of IV type, pressors are given through an infusion pump that allows the dose to be adjusted minute by minute based on blood pressure readings. Patients on pressors have continuous blood pressure monitoring, often through an arterial line that gives a real-time reading with every heartbeat.
Timing Matters
Starting pressors at the right time can affect survival. A 2025 meta-analysis of over 6,600 patients found that initiating vasopressor therapy within one to three hours after a diagnosis of septic shock was associated with a 30% reduction in short-term mortality compared to later starts. Interestingly, extremely early initiation (within the first hour) did not show a clear survival benefit over slightly later timing, suggesting there may be a practical sweet spot where adequate fluid resuscitation happens first, followed promptly by pressors if blood pressure hasn’t recovered.
Risks and Side Effects
Because pressors constrict blood vessels so effectively, they can reduce blood flow to the extremities. Fingers, toes, and skin can become pale or even develop tissue damage in severe cases. This is a known trade-off: the drugs redirect blood toward vital organs at the expense of less critical areas.
One of the more serious complications is extravasation, which occurs when the drug leaks out of the vein and into the surrounding tissue. Because pressors constrict blood vessels, leakage into tissue can cut off local blood supply, potentially causing tissue death. This is rare but requires immediate treatment. The standard rescue involves injecting a counter-agent directly into the affected area to reopen the constricted vessels. If tissue damage is severe, surgical removal of dead tissue may be necessary.
Heart rhythm disturbances are another risk, particularly with pressors that strongly stimulate the heart. This is one reason patients on these medications are in an ICU with continuous cardiac monitoring.
Coming Off Pressors
Pressors aren’t stopped all at once. As the underlying condition improves, whether the infection is being controlled or the heart is recovering, the medical team gradually reduces the dose in a process called weaning. The goal is to confirm that blood pressure can hold steady on its own before the drug is removed entirely.
In practice, clinicians look for signs of stability: blood pressure holding at target levels, adequate urine output (a sign the kidneys are getting enough blood), and improving lab values. The dose is typically lowered in small increments over hours. A successful wean generally means the patient can stay off pressors for at least four hours without blood pressure dropping again. If pressure falls during weaning, the dose goes back up and the team reassesses. Some patients wean off within a day; others need pressors for a week or more depending on how severe the underlying problem is.